Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.20.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Summary of employee and nonemployee stock option activity
A summary of employee and non-employee stock option activity for the three months ended March 31, 2020 for both continuing and discontinuing employees is as follows:
 
Options Outstanding
 
Weighted-
Average
Remaining
Contractual
Term (in years)
 
Aggregate
Intrinsic
Value
(in thousands)
 
Number of
Shares
(in thousands)
 
Weighted-
Average
Exercise
Price
 
Outstanding January 1, 2020
64

 
$
113.63

 
7.48
 
$
24

Granted
20

 
5.53

 
 
 
 
Cancelled or expired
(11
)
 
87.11

 
 
 
 
Outstanding March 31, 2020
73

 
$
88.15

 
7.93
 
$
—

Exercisable March 31, 2020
43

 
$
140.57

 
7.01
 
$
—

Weighted-average assumptions used to estimate fair value of options granted
The following table presents the weighted-average assumptions used to estimate the fair value of options granted to continuing and discontinuing employees during the periods presented:
 
Three Months Ended March 31,
 
2020
 
2019
Volatility
110.43
%
 
90.15
%
Risk free interest rate
1.68
%
 
2.54
%
Dividend yield
0.00
%
 
0.00
%
Term (years)
5.27

 
6.32

Weighted-average fair value of options granted during the period
$
4.45

 
$
10.07

Summary of the effects of stock-based compensation related to stock option and restricted stock awards
The following table presents the effects of stock-based compensation related to stock option and restricted stock awards to employees and non-employees on the Company's continuing operations included in its Unaudited Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) during the periods presented (in thousands):

 
Three Months Ended March 31,
 
2020
 
2019
Cost of revenues
$
4

 
$
4

General and administrative
54

 
115

Total stock-based compensation related to continuing operations
$
58

 
$
119